Volitionrx Stock Performance
| VNRX Stock | USD 0.23 0.01 4.17% |
The entity has a beta of -1.09, which indicates a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Volitionrx are expected to decrease slowly. On the other hand, during market turmoil, Volitionrx is expected to outperform it slightly. At this point, Volitionrx has a negative expected return of -0.42%. Please make sure to validate Volitionrx's value at risk and the relationship between the kurtosis and market facilitation index , to decide if Volitionrx performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Volitionrx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2026. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
1 | VNRX 3Q 2025 results reported Revenues EPS above our expectations cost cutting very evident. At least seven major operational milestones have been achieved thus... | 12/01/2025 |
2 | Disposition of 3698 shares by Forterre Gael of Volitionrx at 0.4875 subject to Rule 16b-3 | 12/05/2025 |
3 | Volition Solves Liquid Biopsys Needle in a Haystack Problem Achieves 180-fold Enrichment | 12/11/2025 |
4 | How rising interest rates impact VolitionRx Limited stock - July 2025 Decliners Weekly Top Stock Performers List - | 12/18/2025 |
5 | VolitionRx Secures 2.0 Million in Funding | 01/08/2026 |
6 | Is VolitionRx Limited subject to activist investor interest - Inflation Watch Reliable Intraday Trade Alerts - baoquankhu1.vn | 01/15/2026 |
7 | D. Boral Capital Reaffirms Buy Rating for VolitionRx | 01/21/2026 |
8 | Acquisition by Jasmine Kway of 42000 shares of Volitionrx subject to Rule 16b-3 | 01/22/2026 |
9 | Volition Announces Data to Support Use of Nu.Q NETs in New Indication | 01/27/2026 |
10 | Disposition of 5647 shares by Nicholas Plummer of Volitionrx at 0.285 subject to Rule 16b-3 | 01/30/2026 |
11 | VolitionRx Receives Notice of Non-Compliance with NYSE American Continued Listing Standards | 02/09/2026 |
12 | Is VolitionRx Limited a cyclical or defensive stock - 2025 Retail Activity AI Based Trade Execution Alerts - mfd.ru | 02/13/2026 |
| Begin Period Cash Flow | 20.7 M | |
| Total Cashflows From Investing Activities | -573.9 K |
Volitionrx | Build AI portfolio with Volitionrx Stock |
Volitionrx Relative Risk vs. Return Landscape
If you would invest 33.00 in Volitionrx on November 19, 2025 and sell it today you would lose (10.00) from holding Volitionrx or give up 30.3% of portfolio value over 90 days. Volitionrx is currently does not generate positive expected returns and assumes 6.1418% risk (volatility on return distribution) over the 90 days horizon. In different words, 55% of stocks are less volatile than Volitionrx, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Volitionrx Target Price Odds to finish over Current Price
The tendency of Volitionrx Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.23 | 90 days | 0.23 | under 95 |
Based on a normal probability distribution, the odds of Volitionrx to move above the current price in 90 days from now is under 95 (This Volitionrx probability density function shows the probability of Volitionrx Stock to fall within a particular range of prices over 90 days) .
Volitionrx Price Density |
| Price |
Predictive Modules for Volitionrx
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Volitionrx. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Volitionrx Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Volitionrx is not an exception. The market had few large corrections towards the Volitionrx's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Volitionrx, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Volitionrx within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.56 | |
β | Beta against Dow Jones | -1.09 | |
σ | Overall volatility | 0.04 | |
Ir | Information ratio | -0.11 |
Volitionrx Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Volitionrx for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Volitionrx can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Volitionrx generated a negative expected return over the last 90 days | |
| Volitionrx has high historical volatility and very poor performance | |
| Volitionrx has some characteristics of a very speculative penny stock | |
| Volitionrx has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 1.23 M. Net Loss for the year was (27.26 M) with profit before overhead, payroll, taxes, and interest of 1.47 M. | |
| Volitionrx currently holds about 16.42 M in cash with (25.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 17.0% of the company outstanding shares are owned by insiders | |
| Latest headline from news.google.com: Is VolitionRx Limited a cyclical or defensive stock - 2025 Retail Activity AI Based Trade Execution Alerts - mfd.ru |
Volitionrx Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Volitionrx Stock often depends not only on the future outlook of the current and potential Volitionrx's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Volitionrx's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 86.5 M | |
| Cash And Short Term Investments | 3.3 M |
Volitionrx Fundamentals Growth
Volitionrx Stock prices reflect investors' perceptions of the future prospects and financial health of Volitionrx, and Volitionrx fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Volitionrx Stock performance.
| Return On Equity | -7.3 | ||||
| Return On Asset | -1.48 | ||||
| Operating Margin | (8.13) % | ||||
| Current Valuation | 41.79 M | ||||
| Shares Outstanding | 135.57 M | ||||
| Price To Earning | (4.52) X | ||||
| Price To Book | 38.44 X | ||||
| Price To Sales | 20.88 X | ||||
| Revenue | 1.23 M | ||||
| Gross Profit | 1.47 M | ||||
| EBITDA | (25.58 M) | ||||
| Net Income | (27.26 M) | ||||
| Cash And Equivalents | 16.42 M | ||||
| Cash Per Share | 0.28 X | ||||
| Total Debt | 5.82 M | ||||
| Debt To Equity | 1.57 % | ||||
| Current Ratio | 1.04 X | ||||
| Book Value Per Share | (0.32) X | ||||
| Cash Flow From Operations | (25.89 M) | ||||
| Earnings Per Share | (0.23) X | ||||
| Market Capitalization | 30.73 M | ||||
| Total Asset | 9.4 M | ||||
| Retained Earnings | (229.54 M) | ||||
| Working Capital | (3.73 M) | ||||
| Current Asset | 6.22 M | ||||
| Current Liabilities | 1.12 M | ||||
About Volitionrx Performance
Evaluating Volitionrx's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Volitionrx has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Volitionrx has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (2.67) | (2.80) | |
| Return On Capital Employed | (19.32) | (18.35) | |
| Return On Assets | (2.58) | (2.71) | |
| Return On Equity | 0.97 | 1.02 |
Things to note about Volitionrx performance evaluation
Checking the ongoing alerts about Volitionrx for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Volitionrx help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Volitionrx generated a negative expected return over the last 90 days | |
| Volitionrx has high historical volatility and very poor performance | |
| Volitionrx has some characteristics of a very speculative penny stock | |
| Volitionrx has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 1.23 M. Net Loss for the year was (27.26 M) with profit before overhead, payroll, taxes, and interest of 1.47 M. | |
| Volitionrx currently holds about 16.42 M in cash with (25.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 17.0% of the company outstanding shares are owned by insiders | |
| Latest headline from news.google.com: Is VolitionRx Limited a cyclical or defensive stock - 2025 Retail Activity AI Based Trade Execution Alerts - mfd.ru |
- Analyzing Volitionrx's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Volitionrx's stock is overvalued or undervalued compared to its peers.
- Examining Volitionrx's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Volitionrx's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Volitionrx's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Volitionrx's stock. These opinions can provide insight into Volitionrx's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Volitionrx Stock Analysis
When running Volitionrx's price analysis, check to measure Volitionrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Volitionrx is operating at the current time. Most of Volitionrx's value examination focuses on studying past and present price action to predict the probability of Volitionrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Volitionrx's price. Additionally, you may evaluate how the addition of Volitionrx to your portfolios can decrease your overall portfolio volatility.